| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10591818 | Bioorganic & Medicinal Chemistry Letters | 2014 | 5 Pages |
Abstract
We describe the discovery and advancement of a novel series of TRPA1 antagonist having an aryl-N-(3-(alkylamino)-5-(trifluoromethyl)phenyl)benzamide scaffold. The physical and in vitro DMPK profiles are discussed.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Sébastien Laliberté, Frédéric Vallée, Pierre-André Fournier, Leanne Bedard, Jean Labrecque, Jeffrey S. Albert,